These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 35900898)

  • 1. Antiplatelet agents and anticoagulants for hypertension.
    Shantsila E; Kozieł-Siołkowska M; Lip GY
    Cochrane Database Syst Rev; 2022 Jul; 7():CD003186. PubMed ID: 35900898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet agents and anticoagulants for hypertension.
    Lip GY; Felmeden DC; Dwivedi G
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD003186. PubMed ID: 22161375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet agents and anticoagulants for hypertension.
    Lip GY; Felmeden DC
    Cochrane Database Syst Rev; 2004; (3):CD003186. PubMed ID: 15266473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
    Shantsila E; Lip GY
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy and anticoagulation in patients with hypertension.
    Griffin G
    Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.
    Bedenis R; Lethaby A; Maxwell H; Acosta S; Prins MH
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD000535. PubMed ID: 25695213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet agents for the treatment of deep venous thrombosis.
    Flumignan CD; Nakano LC; Baptista-Silva JC; Flumignan RL
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012369. PubMed ID: 35876829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic treatment after stroke due to intracerebral haemorrhage.
    Cochrane A; Chen C; Stephen J; Rønning OM; Anderson CS; Hankey GJ; Al-Shahi Salman R
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012144. PubMed ID: 36700520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
    Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery.
    Lewis SR; Pritchard MW; Schofield-Robinson OJ; Alderson P; Smith AF
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012584. PubMed ID: 30019463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents.
    Kahale LA; Matar CF; Tsolakian I; Hakoum MB; Yosuico VE; Terrenato I; Sperati F; Barba M; Hicks LK; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD014739. PubMed ID: 34582035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.
    Bala MM; Paszek E; Lesniak W; Wloch-Kopec D; Jasinska K; Undas A
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012534. PubMed ID: 30004572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic therapy in hypertension: a Cochrane Systematic review.
    Felmeden DC; Lip GY
    J Hum Hypertens; 2005 Mar; 19(3):185-96. PubMed ID: 15674407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis.
    Al Said S; Kaier K; Sumaya W; Alsaid D; Duerschmied D; Storey RF; Gibson CM; Westermann D; Alabed S
    Cochrane Database Syst Rev; 2024 Jan; 1(1):CD014678. PubMed ID: 38264795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for preventing thrombosis in solid organ transplant recipients.
    Surianarayanan V; Hoather TJ; Tingle SJ; Thompson ER; Hanley J; Wilson CH
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD011557. PubMed ID: 33720396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.
    Robertson L; Ghouri MA; Kovacs F
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002071. PubMed ID: 22895926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia.
    Kwan J; Hafdi M; Chiang LLW; Myint PK; Wong LS; Quinn TJ
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012269. PubMed ID: 35833913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Shantsila E; Kozieł M; Lip GY
    Cochrane Database Syst Rev; 2021 May; 5(5):CD003336. PubMed ID: 34002371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulants for people hospitalised with COVID-19.
    Flumignan RL; Civile VT; Tinôco JDS; Pascoal PI; Areias LL; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013739. PubMed ID: 35244208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.